Microbot Medical (NASDAQ:MBOT - Get Free Report) posted its earnings results on Wednesday. The biotechnology company reported ($0.20) earnings per share for the quarter, missing analysts' consensus estimates of ($0.18) by ($0.02), Zacks reports.
Microbot Medical Stock Down 4.6 %
MBOT traded down $0.07 during trading on Friday, hitting $1.46. 497,816 shares of the company traded hands, compared to its average volume of 1,779,625. Microbot Medical has a one year low of $0.82 and a one year high of $3.38. The stock's fifty day moving average is $1.74 and its 200 day moving average is $1.32. The firm has a market cap of $50.73 million, a P/E ratio of -1.82 and a beta of 1.60.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright lifted their price target on Microbot Medical from $7.00 to $9.00 and gave the company a "buy" rating in a research note on Friday, January 24th.
View Our Latest Report on Microbot Medical
About Microbot Medical
(
Get Free Report)
Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.
See Also
Before you consider Microbot Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Microbot Medical wasn't on the list.
While Microbot Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
